(-0.40%) 5 046.50 points
(-0.24%) 37 903 points
(-0.65%) 17 457 points
(-1.48%) $80.72
(-2.81%) $1.935
(0.03%) $2 303.60
(0.21%) $26.71
(0.91%) $956.80
(0.03%) $0.937
(-0.03%) $11.09
(0.12%) $0.801
(0.01%) $93.46
-3.17% $ 17.42
@ $24.14
Wydano: 14 vas. 2024 @ 19:18
Zwrot: -27.84%
Poprzedni sygnał: vas. 12 - 22:20
Poprzedni sygnał:
Zwrot: -4.60 %
Live Chart Being Loaded With Signals
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology...
Stats | |
---|---|
Dzisiejszy wolumen | 283 615 |
Średni wolumen | 247 201 |
Kapitalizacja rynkowa | 489.75M |
EPS | $0 ( 2024-04-03 ) |
Last Dividend | $0.188 ( 2023-11-10 ) |
Next Dividend | $0 ( N/A ) |
P/E | -11.34 |
ATR14 | $0.0280 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Kelley Erika K. | Buy | 0 | |
2024-02-20 | Minor Glenda J | Buy | 95 | Class A Common Stock |
2024-02-20 | Sutherlin Michael W | Buy | 406 | Class A Common Stock |
2024-02-20 | Shoemaker Leslie L | Buy | 43 | Class A Common Stock |
2024-02-20 | Jahnke David L | Buy | 515 | Class A Common Stock |
INSIDER POWER |
---|
-79.24 |
Last 94 transactions |
Buy: 7 552 389 | Sell: 18 343 130 |
Wolumen Korelacja
Radius Health Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
COUP | 0.943 |
APR | 0.931 |
ICON | 0.929 |
FTDR | 0.921 |
ASTL | 0.92 |
DFH | 0.918 |
CRVL | 0.917 |
KIN | 0.915 |
CLBT | 0.904 |
RMRM | 0.902 |
10 Najbardziej negatywne korelacje | |
---|---|
ORRF | -0.913 |
SABS | -0.913 |
MMAC | -0.908 |
LUCD | -0.908 |
VIEW | -0.905 |
AMRB | -0.89 |
SGMA | -0.887 |
LCAP | -0.885 |
LGHL | -0.884 |
TRIT | -0.883 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Radius Health Inc Korelacja - Waluta/Towar
Radius Health Inc Finanse
Annual | 2023 |
Przychody: | $2.88B |
Zysk brutto: | $307.71M (10.68 %) |
EPS: | $-0.920 |
FY | 2023 |
Przychody: | $2.88B |
Zysk brutto: | $307.71M (10.68 %) |
EPS: | $-0.920 |
FY | 2022 |
Przychody: | $3.49B |
Zysk brutto: | $488.07M (14.00 %) |
EPS: | $6.01 |
FY | 2021 |
Przychody: | $229.97M |
Zysk brutto: | $210.82M (91.67 %) |
EPS: | $-1.484 |
Financial Reports:
No articles found.
Radius Health Inc Dividends
(Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.188 (N/A) |
$0.188 (N/A) |
$0.188 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.188 | 2023-04-21 |
Last Dividend | $0.188 | 2023-11-10 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-27 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.563 | -- |
Avg. Dividend % Per Year | 0.60% | -- |
Score | 3.79 | -- |
Div. Sustainability Score | 8.22 | |
Div.Growth Potential Score | 5.28 | |
Div. Directional Score | 6.75 | -- |
Year | Amount | Yield |
---|---|---|
2023 | $0.564 | 1.80% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00339 | 1.500 | 9.93 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00556 | 1.200 | 9.81 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0111 | 1.500 | -0.988 | -1.482 | [0.1 - 1] |
payoutRatioTTM | 2.04 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.927 | 0.800 | 5.36 | 4.29 | [1 - 3] |
quickRatioTTM | 0.883 | 0.800 | 9.51 | 7.61 | [0.8 - 2.5] |
cashRatioTTM | 0.0132 | 1.500 | -1.038 | -1.557 | [0.2 - 2] |
debtRatioTTM | 0.251 | -1.500 | 5.81 | -8.71 | [0 - 0.6] |
interestCoverageTTM | 2.18 | 1.000 | -0.303 | -0.303 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.55 | 2.00 | 7.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.095 | 2.00 | 9.45 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.501 | -1.500 | 7.99 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0989 | 1.000 | -1.685 | -1.685 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0117 | 1.000 | -1.766 | -1.766 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.392 | 1.000 | 8.93 | 8.93 | [0.2 - 2] |
assetTurnoverTTM | 1.639 | 0.800 | 2.41 | 1.926 | [0.5 - 2] |
Total Score | 8.22 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 47.20 | 1.000 | 5.33 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0111 | 2.50 | -0.635 | -1.482 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.095 | 2.00 | 9.64 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.31 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.55 | 2.00 | 7.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 2.04 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.850 | 1.500 | 7.67 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0602 | 1.000 | -0.994 | 0 | [0.1 - 0.5] |
Total Score | 5.28 |
Radius Health Inc
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej